XML 138 R121.htm IDEA: XBRL DOCUMENT v3.22.4
Segment Reporting - Revenue from Segments to Consolidated (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues [1] $ 1,352,013 $ 907,957 $ 924,639
Adjusted EBITDA 106,331 66,317 48,573
Evolent Health Services      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 407,502 309,813 382,360
Clinical Solutions      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 944,511 598,144 542,279
Intersegment Eliminations      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues (869) (1,814) (2,774)
Operating Segments      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 1,352,013 907,957 924,639
Adjusted EBITDA 136,575 99,983 84,595
Operating Segments | Evolent Health Services      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 408,371 311,627 385,134
Adjusted EBITDA 57,936 17,063 57,731
Operating Segments | Clinical Solutions      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 944,511 598,144 542,279
Adjusted EBITDA 78,639 82,920 26,864
Corporate      
Segment Reporting, Revenue Reconciling Item [Line Items]      
Revenues 0 0 0
Adjusted EBITDA $ (30,244) $ (33,666) $ (36,022)
[1] See Note 19 for amounts attributable to unconsolidated related parties included in these line items.